Schonfeld Strategic Advisors LLC Axsome Therapeutics, Inc. Call Options Transaction History
Schonfeld Strategic Advisors LLC
- $14 Billion
- Q1 2024
Call Options
2 transactions
Others Institutions Holding AXSM
# of Institutions
290Shares Held
37.1MCall Options Held
401KPut Options Held
464K-
Rtw Investments, LP New York, NY4.49MShares$360 Million5.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$300 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.2MShares$256 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$189 Million30.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.3MShares$105 Million3.44% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.44B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...